NanoString Technologies has appointed Gary Riordan as VP of quality and regulatory affairs and Kathy Surace-Smith as VP and general counsel.
Riordan formerly was VP of quality and regulatory affairs at Sequenom and director of regulatory affairs at Roche's Ventana Medical Systems.
Surace-Smith recently was VP and general counsel and corporate secretary of SonoSite, and she previously was VP and general counsel at Metawave Communications.
Ariosa Diagnostics has appointed Michael Aicher to its board of directors. He is currently the CEO of Omicia. Previously, he was co-founder and CEO of the National Genetics Institute, a wholly owned subsidiary of Laboratory Corporation of America.